Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egon Persson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|March 30, 2007
Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia ABenny Sørensen, Egon Persson, Jørgen Ingerslev
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Reagent-specific underestimation of turoctocog alfa pegol (N8-GP) clotting activity owing to decelerated activation by thrombinEgon Persson, Tina Foscolo, Martin Hansen
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Underestimation of N-glycoPEGylated factor IX one-stage clotting activity owing to contact activator-impaired activationEgon Persson, Carsten La Cour Christoffersen
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2019
FIXing postinfusion monitoring: Assay experiences with N9-GP (nonacog beta pegol; Refixia<sup>®</sup> ; Rebinyn<sup>®</sup> )Mirella Ezban, Mette Brunsgaard Hermit, Egon Persson
Biochemical and Biophysical Research Communications|September 15, 2006
Inhibitors of factor VIIa affect the interface between the protease domain and tissue factorKarin Carlsson, Egon Persson, Uno Carlsson, et al.
Biochemistry|November 3, 2004
Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIaOle H Olsen, Per F Nielsen, Egon Persson
Protein Science : a Publication of the Protein Society|September 20, 2014
The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factorEgon Persson, Jesper J Madsen, Ole H Olsen
Journal of Thrombosis and Haemostasis : JTH|September 27, 2024
The intricate allostery in factor VIIa: triggering the triggerJesper J Madsen, Egon Persson, Ole H Olsen
The Biochemical Journal|December 23, 2003
Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancementEgon Persson, Helle Bak, Anette Østergaard, et al.
Thrombosis Research|December 17, 2009
Recombinant coagulation factor VIIa--from molecular to clinical aspects of a versatile haemostatic agentEgon Persson, Gert Bolt, Thomas D Steenstrup, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|March 30, 2007
Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia ABenny Sørensen, Egon Persson, Jørgen Ingerslev
Research and Practice in Thrombosis and Haemostasis|January 19, 2019
Reagent-specific underestimation of turoctocog alfa pegol (N8-GP) clotting activity owing to decelerated activation by thrombinEgon Persson, Tina Foscolo, Martin Hansen
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Underestimation of N-glycoPEGylated factor IX one-stage clotting activity owing to contact activator-impaired activationEgon Persson, Carsten La Cour Christoffersen
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2019
FIXing postinfusion monitoring: Assay experiences with N9-GP (nonacog beta pegol; Refixia<sup>®</sup> ; Rebinyn<sup>®</sup> )Mirella Ezban, Mette Brunsgaard Hermit, Egon Persson
Biochemical and Biophysical Research Communications|September 15, 2006
Inhibitors of factor VIIa affect the interface between the protease domain and tissue factorKarin Carlsson, Egon Persson, Uno Carlsson, et al.
Biochemistry|November 3, 2004
Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIaOle H Olsen, Per F Nielsen, Egon Persson
Protein Science : a Publication of the Protein Society|September 20, 2014
The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factorEgon Persson, Jesper J Madsen, Ole H Olsen
Journal of Thrombosis and Haemostasis : JTH|September 27, 2024
The intricate allostery in factor VIIa: triggering the triggerJesper J Madsen, Egon Persson, Ole H Olsen
The Biochemical Journal|December 23, 2003
Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancementEgon Persson, Helle Bak, Anette Østergaard, et al.
Thrombosis Research|December 17, 2009
Recombinant coagulation factor VIIa--from molecular to clinical aspects of a versatile haemostatic agentEgon Persson, Gert Bolt, Thomas D Steenstrup, et al.
Pageof 5